Use of polyethylene-lined silicone rubber cannulae in long-term insulin infusion in the dog.

B. Wigness,T. Rohde,F. Dorman,H. Buchwald

1986-07-01

ASAIO Transactions

Abstract:

What problem does this paper attempt to address?

Calcaneus Fractures With Subluxation of the Posterior Facet: A Surgical Indication

N. Ebraheim,H. Elgafy,F. Sabry,Stanley Tao

DOI: https://doi.org/10.1097/00003086-200008000-00028

IF: 4.755

2000-08-01

Clinical Orthopaedics and Related Research

Abstract:The charts and radiographs of 118 patients with 126 intraarticular fractures of the calcaneus were reviewed retrospectively. Eleven of 126 (8.7%) calcaneal fractures had injuries consisting of intraarticular calcaneal fracture, lateral subluxation or dislocation of the posterior facet, fracture extension into the calcaneocuboid joint, peroneal tendon subluxation, subluxation of the talus in the ankle mortise, and complete disruption of the anterior talofibular and calcaneal fibular ligaments or fracture of the lateral malleolus. There were six women and five men. The average age was 40 years (range, 17-65 years). The mechanism of injury was a motor vehicle accident in eight and a fall from a height in three. According to the classification of Sanders et al eight fractures were Type II, one was Type III, and two were Type IV. Followup at an average of 26 months (range, 14-38 months) showed that eight of 11 patients (72.7%) had either good or excellent results. When lateral subluxation of the posterior facet of the calcaneus is identified with a preoperative computed tomography scan, operative management is indicated, and the surgeon should search for associated injuries that should be addressed at the time of surgery.
Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

Ying-Zheng Zhao,Xing Li,Cui-Tao Lu,Yan-Yan Xu,Hai-Feng Lv,Dan-Dan Dai,Lu Zhang,Chang-Zheng Sun,Wei Yang,Xiao-Kun Li,Ya-Ping Zhao,Hong-Xing Fu,Lu Cai,Min Lin,Li-Juan Chen,Ming Zhang

DOI: https://doi.org/10.1007/s00592-011-0356-z

2011-01-01

Acta Diabetologica

Abstract:Polymeric nanoparticles are widely used as targeted carriers for biomacromolecules. In this paper, modified gelatin nanoparticles were prepared and their feasibility as insulin pulmonary administration system was investigated. d , l -glyceraldehyde and poloxamer 188 were used for gelatin nanoparticle preparation. Novel water-in-water emulsion technique was used to prepare insulin-loaded nanoparticles. Morphological examination of insulin-loaded nanoparticles was carried out using scanning electron microscopy (SEM). Intratracheal instillation of insulin-loaded nanoparticles was performed to evaluate animal hypoglycemic effect. With fluorescence labeling of insulin, alveolar deposition and absorption of insulin-loaded nanoparticles were investigated. Histological changes in the lung were also observed to evaluate the safety. From the micromorphology observation, insulin-loaded nanoparticles under gelatin–poloxamer 188 ratio at 1:1 showed smooth and uniform surface, with average particle size 250 nm and Zeta potential −21.1 mV. From animal experiment, insulin-loaded nanoparticles under gelatin–poloxamer 188 ratio at 1:1 promoted insulin pulmonary absorption effectively and showed good relative pharmacological bioavailability. Proved by alveolar deposition result, FITC-insulin-loaded nanoparticle group was characterized by an acute and rapid hypoglycemic effect. In addition, nanoparticles could guarantee the safety of lung by reducing insulin deposition in lung. A transient weak inflammatory response was observed at 1 day after administration. With good physical characterization, high bioavailability, fast and stable hypoglycemic effect, insulin-loaded nanoparticles might be developed as a novel insulin pulmonary system for diabetes therapy.
In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time

Jasmin R. Kastner,Gabriella Eisler,Marc C. Torjman,Abdurizzagh Khalf,David Diaz,Alek R. Dinesen,Channy Loeum,Paul J. Strasma,Jeffrey I Joseph

DOI: https://doi.org/10.1177/19322968221093362

2022-05-10

Journal of Diabetes Science and Technology

Abstract:Journal of Diabetes Science and Technology, Ahead of Print. Background:Infusion set function remains the limiting factor of insulin pump therapy due to nonmetabolic complications. Here, we tested an investigational extended-wear infusion set prototype with a soft, angled, wire-reinforced cannula with three additional side holes, and compared failure mechanisms and tissue response with a commercial Teflon control.Methods:A total of 48 Teflon and 48 prototype infusion sets were inserted subcutaneously every other day for 14 days in 12 swine and infused with dilute insulin. After two weeks, tissue around cannulas was excised, and occlusions, leaks, and kinks were determined. Tissue was processed and stained to assess the total area of inflammation (TAI) and the inflammatory layer thickness (ILT) around the cannulas. Data were analyzed using Fisher's exact, analysis of variance-general linear model, Kruskal-Wallis, and post hoc tests.Results:On average, the TAI surrounding the investigational cannula was 52.6% smaller than around the commercial control. The ILT was 66.3% smaller around investigational cannulas. Kinks occurred in 2.1% (investigational) vs 32.4% (commercial) cannulas (P < .001). There was no difference in occlusion alarms and leaks onto skin.Conclusions:The data suggest that the infusion set prototype elicits less inflammation over an extended wear time and is resistant to kinking, compared with a commercial Teflon device. This is consistent with previously published data on the impact of cannula material/angle on the inflammatory tissue response. We highlight the following important aspects of infusion set design: (1) secure skin adhesion, (2) reliable cannula insertion, (3) automatic removal of the stylet, (4) cannula material/design that resists kinking, and (5) minimization of local tissue inflammation.
Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs

Sean E Hulsebosch,Jully Pires,Michael J Bannasch,Thomas Lancaster,Andrea Delpero,Ramya Ragupathy,Sylaja Murikipudi,Todd Zion,Chen Gilor

DOI: https://doi.org/10.1111/jvim.16449

Abstract:Background: For the treatment of diabetes mellitus (DM) in dogs, novel insulins with decreased injection frequency while maintaining safety and efficacy are desirable. Insulin fused with immunoglobulin-fragment-crystallizable (Fc) has an ultra-long plasma half-life because it recycles through cells, protected from proteolysis. Hypothesis: Glycemic control can be achieved in diabetic dogs with a recombinant fusion protein of a synthetic insulin and canine Fc (AKS-218d) administered subcutaneously once-weekly. Animals: Five client-owned dogs with naturally occurring DM. Methods: Prospective clinical trial in dogs with DM that were recruited from the UC Davis Veterinary Teaching Hospital and local veterinary clinics. Dogs previously controlled using intermediate-acting insulin q12h were transitioned to once-weekly injections of a preliminary construct identified as AKS-218d. The dose of AKS-218d was titrated weekly for 8 weeks based on clinical response and continuous interstitial glucose monitoring. Clinical signs, body weight, serum fructosamine concentrations, and mean interstitial glucose concentrations (IG) over the preceding week were compared between baseline (before AKS-218d) and during the last week of treatment. Data were compared using nonparametric paired tests. Results: Once-weekly AKS-218d, compared to baseline twice-daily insulin therapy, resulted in no significant changes in clinical signs, median (range) body weight (+0.4 kg [-0.5-1.1]; P = .6), fructosamine concentration (-75 mmol/L [-215 to +126]; P = .4), or mean IG (+81 mg/dL [-282 to +144]; P = .8). No adverse reactions were reported. Conclusion: Control of clinical signs, body weight, and maintenance of glycemia was achieved with this once-weekly novel insulin construct in 4 of 5 dogs.
[Staging and profiling of patients with dual disorders].

A. Neven,A. van Wamel,W. van den Brink

Tijdschrift voor Psychiatrie

Abstract:BACKGROUND Although there is a great need for staging and profiling in psychiatry, no-one has so far devised a staging and profiling model to aid diagnosis and treatment. AIM To devise a basic staging and profiling strategy that can be used to treat patients suffering from both substance abuse disorder and a psychiatric disorder. METHOD On the basis of existing staging model for addiction, we explore how staging could also be useful for the treatment of comorbidity in psychiatry. RESULTS Since there is hardly any evidence of the use of staging for this kind of comorbidity, we present a staging model that might help to provide a solution. To the described stages we add a recommended treatment setting or treatment intensity. CONCLUSION Further research is needed to ascertain whether the staging model that we have presented will lead to improvements in the prognosis and treatment of patients with dual disorders referred to Dutch psychiatrists.
A Glucose‐responsive Cannula for Automated and Electronics‐free Insulin Delivery

Stephanie Fuchs,Julia S. Caserto,Qingsheng Liu,Kecheng Wang,Kaavian Shariati,Chase M. Hartquist,Xuanhe Zhao,Minglin Ma

DOI: https://doi.org/10.1002/adma.202403594

IF: 29.4

2024-04-20

Advanced Materials

Abstract:Automated delivery of insulin based on continuous glucose monitoring is revolutionizing the way insulin‐dependent diabetes is treated. However, challenges remain for the widespread adoption of these systems, including the requirement of a separate glucose sensor, sophisticated electronics and algorithms, and the need for significant user input to operate these costly therapies. Herein, we report a user‐centric glucose‐responsive cannula for electronics‐free insulin delivery. The cannula —made from a tough, elastomer‐hydrogel hybrid membrane formed through a one‐pot solvent exchange method— changes permeability to release insulin rapidly upon physiologically relevant varying glucose levels, providing simple and automated insulin delivery with no additional hardware or software. Two prototypes of the cannula were evaluated in insulin‐deficient diabetic mice. The first cannula —an ends‐sealed, subcutaneously inserted prototype— normalized blood glucose levels for three days and controlled postprandial glucose levels. The second, more translational version —a cannula with the distal end sealed and the proximal end connected to a transcutaneous injection port— likewise demonstrated tight, three‐day regulation of blood glucose levels when refilled twice daily. This proof‐of‐concept study may aid in the development of "smart" cannulas and next‐generation insulin therapies at a reduced burden‐of‐care toll and cost to end‐users. This article is protected by copyright. All rights reserved

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
Innovative application of an implantable venous access system in the portal vein: technique, results and complications in three dogs

Kiona S. de Nies,Hedwig S. Kruitwagen,Giora van Straten,Leonie W. L. van Bruggen,Joris H. Robben,Baukje A. Schotanus,Ies Akkerdaas,Anne Kummeling

DOI: https://doi.org/10.1186/s12917-019-1986-6

2019-07-11

BMC Veterinary Research

Abstract:<h3 class="Heading">Background</h3><p class="Para">Vascular access port (VAP) systems are widely used in human medicine to provide long-term venous access. However, in veterinary medicine the use of VAP systems is not common practice and publications on their potential applications have been limited. A VAP system was used as part of an experimental study on liver regeneration and implanted in the canine portal vein to create direct access to the portal venous circulation of the liver. The aim of the present study is to describe the surgical technique, its use, and the complications of a VAP system in three research dogs.</p><h3 class="Heading">Results</h3><p class="Para">The VAP system was successfully used for the intraoperative measurement of portal blood pressure, the administration of cell suspensions, and the collection of portal venous blood samples. Long-term complications consisted of dislocation of the VAP system in one dog (2 months after implantation) and thrombus formation at the catheter tip in two dogs (3 months after implantation). Both complications prevented further use of the VAP but had no adverse clinical implications.</p><h3 class="Heading">Conclusions</h3><p class="Para">This pilot study suggests that the VAP system is an effective and safe technique to obtain long term access to the portal venous system in dogs. However, complications with port detachment and thrombosis may limit long term use of VAPs in the portal system of dogs.</p>

veterinary sciences
Sutureless Choledochoduodenostomy with an Intraluminal Degradable Stent in Dog Model.

Zhu Ling-hua,Liang Xiao,Lin Hui,Wang Yi-fan,Zhu Yi-ping,Cai Xiu-jun

DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.2011.13.014

2011-01-01

Abstract:Background It is difficult and time-consuming for carrying out conventional hand-sewn bilioenteric anastomosis, especially for small bile duct anastomosis and laparoscopic procedure. In order to simplify it, we have developed a novel procedure of sutureless bilioenteric anastomosis with an intraluminal degradable stent. This study aimed to evaluate the feasibility and safety of this technique with cholangioduodenostomy in dog model.Methods A patent intraluminal degradable stent tube for sutureless choledochoduodenostomy in dog model was made with polylactic acid in diameter of 3 mm or 4 mm. Thirty-eight dogs were randomly divided into to a stent group (SG, n=20) and a control group (CG, n=18). Dogs in the SG underwent sutureless choledochoduodenostomy with intraluminal stent, while the CO underwent conventional choledochoduodenostomy (single layer discontinuous anastomosis with absorbable suture). Dogs of each group were divided into 4 subgroups according to time of death (1, 3, 6, and 12 months postoperatively) to evaluate the healing of anastomosis. Operation time, intraoperative tolerance pressure of anastomosis, rate of postoperative bile leakage, bursting pressure of anastomosis were compared between the two groups. Anastomosis tissue was observed afterwards by pathology evaluation, hydroxyproline content, serum bilirubin, liver enzyme level and magnetic resonance cholangio-pancreatography (MRCP) to assess the stricture.Results All procedures were completed successfully. The surgical time of the SG was significantly less than the CG (SG: (19.2+/-4.3) minutes, vs. CG: (29.2+/-7.1) minutes, P=0.000). One bile leakage was occurred in either group. No significant difference of intraoperative tolerance pressure of anastomosis, rate of bile leakage and postoperative bursting pressure of anastomosis, anastomotic stricture, hydroxyproline content, serum bilirubin and liver enzyme level was found between the two groups. MRCP showed no anastomosis stricture and obstruction during months of follow-up.Conclusion The technique of sutureless choledochoduodenostomy with a degradable intraluminal stent is feasible and a safe procedure in this dog model. Chin Med J 2011;124(13):1999-2003
[Intestinal absorption of insulin with a new telemetric shuttle in dogs]

C Rodier-Bruant,F Vaxman,A Lambert,D Wagner,G Coumaros,J P Vaultier,M Koenig,J F Grenier

Abstract:Telemetric shuttles for the in vivo investigation of the gastrointestinal tract have been available for sometime. We describe herein the use of a new shuttle model whose original features include: a) continuous, real time transmission of its location in the small bowel and accurate measurement of the gut length, b) controlled release of 1 ml of a given substance at any chosen site, allowing detailed investigation of intestinal absorption at different levels of the small bowel under physiological conditions. Small bowel length was measured in dogs using the shuttle and was later compared to the actual small gut length measured in the same animals at laparotomy. The telemetric measurements appeared to closely match the direct operative measurements. Insulin absorption from the canine small bowel was then investigated releasing different dosages of insulin together with the pancreatic enzyme inhibitors Soybean and Aprotinine and a surfactant (5-methoxysalicylate). By adjusting the dose of insulin released, the type of adjuvant substance delivered with it and the site of release in the small bowel, we have been able to precisely define the conditions of insulin absorption. Insulin as such is exclusively absorbed in the ileum when released in doses of 500 IU or higher and mixed with aprotinine. For absorption to take place the solution delivered by the shuttle needs to have the correct pH and natremic concentration.
Induction of Bone Marrow CD34+ Cells and Endothelialization of Polytetrafluoroethylene Prostheses.

Nan Zhang,Hongkun Zhang,Shiping Han,Hua Feng,Jiahui Li,Wei Jin,Zhonggao Wang

DOI: https://doi.org/10.1111/j.1445-2197.2007.04097.x

2007-01-01

Abstract:Background: The aim of the study was to investigate the endothelialization of prostheses with bone marrow CD34(+) cells.Methods: CD34(+) cells were isolated from the canine bone marrow by an immune magnetic cell sorting system and induced into endothelial cells (EC) with vascular endothelial growth factor. Cells were seeded to polytetrafluoroethylene prostheses, which were implanted into the abdominal aorta artery and inferior vena cava.Results: The isolated cells derived from bone marrow were CD34(+) cells by flow cytometery, which could differentiate into EC when induced by vascular endothelial growth factor. The neointima on control prostheses was significantly thicker than that on prostheses seeded with EC at the anastomosis and the centre where the prosthesis interposed to aorta. All control prostheses (4/4) interposed to veins were occlusive and two seeded prostheses (2/8) interposed to veins were already occluded. The overall occlusion rate of prostheses interposed to veins in seeded prostheses and control prostheses were 25 and 100%, respectively. However, the neointima on seeded prostheses was significantly thicker in the vein than that in the aorta.Conclusion: Bone marrow CD34(+) cells can be induced into EC by vascular endothelial growth factor in vitro. Polytetrafluoroethylene prostheses seeded with CD34(+) cells have the ideal endothelialization and patency.
Improved simple T-cannula technique to facilitate surgery and daily skin care of growing pigs

Barbara U Metzler-Zebeli,Pia Rosenfelder-Kuon,Helga Brehm,Meike Eklund,Rainer Mosenthin

DOI: https://doi.org/10.1093/jas/skaa091

2020-04-01

Abstract:In order to further increase the stability of the cannula behind the ribs and to facilitate cannula exteriorization in growing pigs, the present study aimed to evaluate whether elongation of the cannula flange could increase the stability of the cannula behind the ribs and to develop a tool to improve the exteriorization of the cannula through the ribs. Moreover, it was assessed whether a special skin protection paste and soft polyurethane foam material used in daily skin care could prevent erythema around the fistula. The feasibility of both, the modified simple T-cannula and daily skin care procedure, was evaluated in a digestibility experiment. Simple T-cannulae were made of high-molecular-weight polyethylene and inserted into the distal ileum of eight growing pigs (average body weight at surgery 30 kg). Modifications in the cannula design included a longer flange (11 cm) that was narrowed from the center to the ends and a bending of the flange to adapt it to the curve of the costal arch. In order to reduce the damage to the thread on the outer cannula barrel during surgery, a special surgical plug in conjunction with a screw thread on the inside of the barrel was developed. With respect to the daily cleaning of the fistula, a special skin protection paste was applied on the skin around the fistula to create a waterproof film that entirely sealed the skin. Additionally, foam material was inserted between the retaining ring and the skin to absorb the leaking digesta. Monitoring of the pigs throughout the trial showed that modifications in cannula design proved to be useful as they facilitated exteriorization of the cannula through the ribs and stability of the cannula behind the ribs. Moreover, the use of the skin protection paste and foam material during postsurgical treatment of growing pigs effectively prevented skin irritation around the flank area.
Experimental study on hemocompatibility of domestic silicone-covered stent

Wen-tao LI,Jian-hua WANG,Qing-xin LIU,Xu-dong QU

DOI: https://doi.org/10.3969/j.issn.1008-794X.2005.02.020

2005-01-01

Abstract:Objective To evaluate the hemocompatibility of domestic silicone-covered stent in the iliac arteries of canine model. Methods Eighteen domestic stents were placed in ililac arteries of 9 adult dogs after larger ballon PTA, which included 10 silicone-covered stents and 8 bare stents for control. DSA was performed at 1,4,12 weeks after stent implantation in the iliac arteries of two groups to observe the outcomes of patency or restenosis. Animals were then euthanized isolating and stainning the stented arteries with hematoxylin and eosin for histological examination. Finally, the acute thrombosis, reendothelialization and the neointimal proliferation of both covered and bare stents were quantified on histological cross-section. Results All bare stents were patent in 12 weeks, but two silicone-covered stents were occluded at 4,12 week respectively (patent rate was 80%). Stented vascular stenosis rate was averaging 72.3% at 12 week in covered stents and 36.7% in bare stents. Conclusions The hemocompatibility of silicone-covered stents is not better than that of bare stents. Silicone appear to be inert in this experimental application.
Insulin Therapy in Small Animals, Part 3: Dogs

Linda Fleeman,Chen Gilor

DOI: https://doi.org/10.1016/j.cvsm.2023.02.003

Abstract:Insulin therapy should ideally mimic a basal-bolus pattern. Lente, NPH, NPH/regular mixes, PZI, glargine U100, and detemir are intermediate-acting formulations that are administered twice daily in dogs. To minimize hypoglycemia, intermediate-acting insulin protocols are usually geared towards alleviating (but not eliminating) clinical signs. Insulin glargine U300 and insulin degludec meet the criteria for an effective and safe basal insulin in dogs. In most dogs, good control of clinical signs is achieved when using a basal insulin alone. In a small minority, bolus insulin at the time of at least one meal per day may be added to optimize glycemic control.
Longevity of the novel ConvaTec infusion set with Lantern technology

Rayhan A. Lal,Liana Hsu,Jian Zhang,Pernelle K. Schøndorff,Matthias Heschel,Bruce Buckingham

DOI: https://doi.org/10.1111/dom.14395

2021-04-18

Diabetes, Obesity and Metabolism

Abstract:Current insulin infusion sets are approved for only 2‐3 days. The novel ConvaTec infusion set with Lantern Technology is designed to extend infusion set wear time. The goal of this pilot study was to evaluate duration of wear for this set. This was a pilot safety study in adults with type 1 diabetes using tethered insulin pumps. Participants inserted the set and wore it for 10 days or until failure. Among 24 participants, 2 were excluded. 45% of the sets lasted 10 days. Median wear time was 9.1 (7.1,10.0) days. Among 12 premature failures: 6 (50%) involved adhesive failures, 4 (33%) hyperglycemia unresponsive to correction, 1 (8%) hyperglycemia with ketones and 1 (8%) infection. Average CGM glucose per day of infusion set wear demonstrated a statistically significant increase over time, while total daily insulin over the same period did not change. In this pilot study the duration of wear for the novel infusion set exceeded previously reported commercial sets (p<0.001). This extended wear technology may eventually allow for a combined glucose sensor and infusion set.This article is protected by copyright. All rights reserved.
In Vivo Wound-Healing Efficacy of Insulin-Loaded Strontium-Cross-Linked Alginate-Based Hydrogels in Diabetic Rats

G. P. Rajalekshmy,Rekha M. Ramesan,C. Surendran Geetha,Kanakarajan V. Pratheesh,Sachin J. Shenoy,Thapasimuthu V. Anilkumar

DOI: https://doi.org/10.1021/acsbiomaterials.3c01692

2024-03-07

ACS Biomaterials Science & Engineering

Abstract:The wound-healing effect of insulin is well studied and reported. However, prolonged topical application of insulin without compromising its biological activity is still a challenge. In this study, the effect of topically delivered insulin on promoting wound healing in diabetic animals was evaluated. Alginate diamine PEG-<i>g</i>-poly(PEGMA) (ADPM2S2) was the material used for the topical delivery of insulin. ADPM2S2 hydrogels release insulin and strontium ions, and they synergistically act to regulate different phases of wound healing. Insulin was released from the ADPM2S2 hydrogel for a period of 48 h, maintaining its structural stability and biological activity. <i>In vitro</i> studies were performed under high-glucose conditions to evaluate the wound-healing potential of insulin. Insulin-loaded ADPM2S2 hydrogels showed significant improvement in cell migration, proliferation, and collagen deposition, compared to control cells under high-glucose conditions. Immunostaining studies in L929 cells showed a reduction in phospho Akt expression under high-glucose conditions, and in the presence of insulin, the expression increased. The gene expression studies revealed that insulin plays an important role in regulating the inflammatory phase and macrophage polarization, which favors accelerated wound closure. <i>In vivo</i> experiments in diabetic rat excision wounds treated with insulin-loaded ADPM2S2 showed 95% wound closure within 14 days compared with 82% in control groups. Thus, both the <i>in vitro</i> and <i>in vivo</i> results signify the therapeutic potential of topically delivered insulin in wound management under high-glucose conditions.

materials science, biomaterials
Enhanced cutaneous wound healing in rats following topical delivery of insulin-loaded nanoparticles embedded in poly(vinyl alcohol)-borate hydrogels

Dalia H Abdelkader,Murtaza M Tambuwala,Christopher A Mitchell,Mohamed A Osman,Sanaa A El-Gizawy,Ahmed M Faheem,Mohamed El-Tanani,Paul A McCarron

DOI: https://doi.org/10.1007/s13346-018-0554-0

Abstract:Insulin plays an important role in the wound healing process, but its method of delivery to the wound bed and subsequent effect on rate of healing is less well investigated. In this study, we evaluated the therapeutic effectiveness of topical human insulin delivery using a nanoparticulate delivery system suspended in a structured hydrogel vehicle. Poly(lactide-co-glycolide) (PLGA) nanoparticles (NP) of 202.6 nm diameter and loaded with 33.86 μg insulin per milligram of polymer were formulated using a modified double-emulsion solvent evaporation technique and dispersed in a dilatant hydrogel (poly(vinyl alcohol)-borate). Importantly, this hydrogel formulation was used to achieve ultimate contact with the wound bed. A comparison of wound healing rates following local administration of insulin in the free and nanoencapsulated forms was performed in diabetic and healthy rats. In non-diabetic rats, there was no significant difference between healing observed in control and wounds treated with free insulin (p > 0.05), whereas treatment with insulin encapsulated within PLGA NP showed a significant difference (p < 0.001). In diabetic cohorts, both free insulin and nanoencapsulated insulin induced significant improvement in wound healing when compared to controls, with better percentage wound injury indices observed with the colloidal formulation. At day 10 of the experiment, the difference between percentage wound injury indices of insulin-PLGA NP and free insulin comparing to their controls were 29.15 and 12.16%, respectively. These results support strongly the potential of insulin-loaded colloidal carriers for improved wound healing when delivered using dilatant hydrogel formulations.
Long-term intravenous infusion technique in unrestrained rats

伍晓汀,李宁,黎介寿

DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.1998.06.155

1998-01-01

Abstract:Objective:To develop a reliable technique that provides not only a route for continuous ntravenous administration of drugs, but an easy access for TPN support in unrestrained small animals as well.Methods:A fluid infusion swivel system with implanting and maintaining venous catheter in the superior vena cava of rats was designed. The system administered a long-term intravenous infusion in unrestrained rats.Results:The average period of 98 heterotopic small bowel transplanted rats receiving infusion was 10days, and the infusion was maintained for more than 3 weeks in some rats. All animals appeared to tolerate infusion catheter without obvious discomfort and with minimal restriction of their motion. Kinking and leakage did not occur anymore.Conclusion:This swivel system can be readily utilized and has great potential value for studying problems related to surgical nutrition and metabolism.
Performance of islets of Langerhans conformally coated via an emulsion cross-linking method in diabetic rodents and nonhuman primates

Aaron A. Stock,Grisell C. Gonzalez,Sophia I. Pete,Teresa De Toni,Dora M. Berman,Alexander Rabassa,Waldo Diaz,James C. Geary,Melissa Willman,Joy M. Jackson,Noa H. DeHaseth,Noel M. Ziebarth,Anthony R. Hogan,Camillo Ricordi,Norma S. Kenyon,Alice A. Tomei

DOI: https://doi.org/10.1126/sciadv.abm3145

IF: 13.6

2022-06-30

Science Advances

Abstract:Polyethylene glycol (PEG)–based conformal coating (CC) encapsulation of transplanted islets is a promising β cell replacement therapy for the treatment of type 1 diabetes without chronic immunosuppression because it minimizes capsule thickness, graft volume, and insulin secretion delay. However, we show here that our original CC method, the direct method, requiring exposure of islets to low pH levels and inclusion of viscosity enhancers during coating, severely affected the viability, scalability, and biocompatibility of CC islets in nonhuman primate preclinical models of type 1 diabetes. We therefore developed and validated in vitro and in vivo, in several small- and large-animal models of type 1 diabetes, an augmented CC method—emulsion method—that achieves hydrogel CCs around islets at physiological pH for improved cytocompatibility, with PEG hydrogels for increased biocompatibility and with fivefold increase in encapsulation throughput for enhanced scalability.

multidisciplinary sciences
Long‐term intraperitoneal access with description of a new access catheter

Villarejo Campos Pedro,Bruce‐White Edward,García Arranz Mariano,Siyuan Qian,Pedro Antonio,Campos Cascales,García Olmo Damián,Martínez Albalat Alberto

DOI: https://doi.org/10.1002/jso.27843

2024-08-27

Journal of Surgical Oncology

Abstract:Background and Objectives Intraperitoneal chemotherapy can be administered as a single dose associated with hyperthermia (HIPEC) or in successive doses under normothermic conditions, such as early postoperative intraperitoneal chemotherapy (EPIC) or normothermic intraperitoneal chemotherapy (NIPEC or NIPEC‐LT). Repetitive administration of intraperitoneal chemotherapy over a prolonged period may be associated with catheter‐related complications, which are the primary cause of treatment interruption. This study aims to introduce and evaluate an innovative catheter system designed to mitigate these issues. Methods Using a porcine experimental model, we tested a new catheter for long‐term intraperitoneal access. Sixteen animals underwent catheter implantation followed by normothermic recirculation of peritoneal dialysis solution. Catheter functionality and any complications were monitored throughout successive treatment cycles. Results The new catheter system demonstrated optimal recirculation and maintained its functionality throughout successive treatments, without complications. Catheter replacement with a guidewire was successful, ensuring continued efficacy. Conclusions The innovative catheter system shows promise in reducing complications and improving compliance in successive intraperitoneal chemotherapy doses, justifying further clinical trials to confirm its efficacy in patients.

oncology,surgery
Survival assessment of the extended‐wear insulin infusion set featuring lantern technology in adults with type 1 diabetes by the glucose clamp technique

Amra Simic,Pernelle K. Schøndorff,Tobias Stumpe,Matthias Heschel,Werner Regittnig,Tina Pöttler,Daniela Ninaus,Thomas Augustin,Andrea Groselj‐Strele,Thomas R. Pieber,Julia K. Mader

DOI: https://doi.org/10.1111/dom.14337

2021-03-04

Diabetes, Obesity and Metabolism

Abstract:Maintaining good glycemic control with the same infusion set for longer than three days may improve quality of life of insulin pump users. The aim of the present study was to assess the efficacy and safety of the novel, extended‐wear infusion set over seven days of wear in adults with type 1 diabetes. Sixteen participants completed three identical 8‐hour euglycemic clamp experiments on days 1, 4, and 7 of infusion set wear. Between the experiments, the participants were discharged home for routine diabetes management while wearing the same extended‐wear infusion set throughout the study. Time to reach the maximum glucose infusion rate (TGIRmax) on day 7 was reduced by 67% compared to day 1 (p<0.001). The corresponding area under the glucose infusion rate curve (AUCGIR) was comparable for the first two hours of the clamp (p=0.891) but decreased by 28% over time (p<0.008). While the extent of insulin absorption decreased with prolonged wear, it was accompanied by an increase in insulin absorption rate. The infusion set survival rate was 100% without leakages, occlusion alarms, severe hypoglycemia or ketoacidosis. The extended‐wear infusion set proved safe and effective during prolonged wear in real‐life conditions.This article is protected by copyright. All rights reserved.

Use of polyethylene-lined silicone rubber cannulae in long-term insulin infusion in the dog.

Calcaneus Fractures With Subluxation of the Posterior Facet: A Surgical Indication

Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time

Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs

[Staging and profiling of patients with dual disorders].

A Glucose‐responsive Cannula for Automated and Electronics‐free Insulin Delivery

Innovative application of an implantable venous access system in the portal vein: technique, results and complications in three dogs

Sutureless Choledochoduodenostomy with an Intraluminal Degradable Stent in Dog Model.

[Intestinal absorption of insulin with a new telemetric shuttle in dogs]

Induction of Bone Marrow CD34+ Cells and Endothelialization of Polytetrafluoroethylene Prostheses.

Improved simple T-cannula technique to facilitate surgery and daily skin care of growing pigs

Experimental study on hemocompatibility of domestic silicone-covered stent

Insulin Therapy in Small Animals, Part 3: Dogs

Longevity of the novel ConvaTec infusion set with Lantern technology

In Vivo Wound-Healing Efficacy of Insulin-Loaded Strontium-Cross-Linked Alginate-Based Hydrogels in Diabetic Rats

Enhanced cutaneous wound healing in rats following topical delivery of insulin-loaded nanoparticles embedded in poly(vinyl alcohol)-borate hydrogels

Long-term intravenous infusion technique in unrestrained rats

Performance of islets of Langerhans conformally coated via an emulsion cross-linking method in diabetic rodents and nonhuman primates

Long‐term intraperitoneal access with description of a new access catheter

Survival assessment of the extended‐wear insulin infusion set featuring lantern technology in adults with type 1 diabetes by the glucose clamp technique